This MAb reacts with a membrane-associated protein present in normal and malignant neuroendocrine tissues including small cell lung cancer (SCLC). It stains neural and a variable number of endocrine tissues and in the lung it reacts preferentially with SCLC and carcinoids. Its epitope is destroyed during formalin fixation. This antibody was categorized during the First International Workshop on Small Cell Lung Cancer Antigens held in London in April 1987. There are two major types of Lung Carcinoma: non-small cell, which accounts for 80% of all cases; and small cell, which accounts for roughly 20% of all lung cancers reported. The lung continues to be a customary place for cancer migration from tumors elsewhere in the body. Treatment depends on the specific cell type of the cancer, level of progression and status of the individual patient.
Host
Mouse
Immunogen
Lung Cancer-associated antigen isolated from small cell lung carcinoma-derived cell line
Positive Control
Human small cell lung carcinoma, adrenal gland
Reactivity
Human
Recombinant
FALSE
Regulatory
RUO
Swissprot
Not Known
Uniprot
Not Known
Gene Id
Not Known
Buffer
200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA; 0.05% azide. Also available WITHOUT BSA; azide at 1.0mg/ml.
Concentration
1.0mg/ml
Description
There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
Applications
IF, IHC(fro)
Description
Optimal dilution for a specific application should be determined., IF ; IHC(fro)
Dilution
IF
0.5-1μg/ml
IHC(fro)
0.5-1.0μg/ml for 30 minutes at RT
Reviews of Anti-Small Cell Lung Carcinoma Antigen Antibody BHA10207448